Active	Status	Sponsor type	Region	Phase	Filter
7 Active 0 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Böning, Andreas
ODIN, NCT05997693: One-Month DAPT in CABG Patients	Recruiting	3	700	Europe, Canada, US	Ticagrelor 90 MG, Low-dose aspirin	Weill Medical College of Cornell University, Canadian Institutes of Health Research (CIHR)	Chronic Coronary Disease	01/27	01/31
AKITA, NCT05126303: Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery	Terminated	2	177	Europe, Canada, US, RoW	RMC-035, ROSgard, Placebo	Guard Therapeutics AB	Acute Kidney Injury	04/23	07/23
POINTER, NCT06475274: A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery	Recruiting	2	161	Europe, Canada	RMC-035, Placebo	Guard Therapeutics AB	Kidney Injury Following Open-Chest Cardiac Surgery	10/25	10/25
NCT03753607: Renal Venous Flow and Cardiac Surgery-associated Acute Kidney Injury	Completed	N/A	200	Europe	No intervention	University of Giessen	Acute Kidney Injury, Cardiorenal Syndrome	01/22	11/23
HARVITA, NCT05931783: Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery	Recruiting	N/A	1350	Europe	skeletonized harvesting technique, pedicled harvesting technique	Medical University Innsbruck	Coronary Artery Disease	10/28	10/31
Gabor, Szabo
AKITA, NCT05126303: Efficacy and Safety of RMC-035 in Subjects at High Risk for Acute Kidney Injury Following Open-Chest Cardiac Surgery	Terminated	2	177	Europe, Canada, US, RoW	RMC-035, ROSgard, Placebo	Guard Therapeutics AB	Acute Kidney Injury	04/23	07/23
POINTER, NCT06475274: A Phase 2b Dose Finding Study of RMC-035 in Participants Undergoing Open-chest Cardiac Surgery	Recruiting	2	161	Europe, Canada	RMC-035, Placebo	Guard Therapeutics AB	Kidney Injury Following Open-Chest Cardiac Surgery	10/25	10/25